🔗 Share this article

A shadow market for unlicensed weight-loss medications is propelled by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.

Experimental Drug Gaining Popularity Online

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Followers are encouraged to message these accounts privately for supplier links, while also obtaining discount codes.

Active Trade on Social Networks

Separately, a robust trade exists on Telegram, where communities with thousands of members share “before and after” photos, injection guides and assertions of next-day British shipping. Vendors promote the drug there before directing customers to WhatsApp for purchases.

Learning About The Experimental Drug

This medication is an investigational injectable created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Experts Express Worries

Nevertheless, doctors and chemists have warned that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could lead to users injecting substances of unknown origin.

Some experts stated the popularity for retatrutide could be linked to the rising price of licensed slimming products such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.

Some influencers try to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still violate medicines, marketing, and customer regulations, risking fines, legal action or prison.

Platform Response and Material Removal

Based on TikTok, the platform has removed violative content and prohibited associated hashtags and search suggestions. The company said it was dedicated to maintaining the platform secure and investing in strengthening compliance measures.

Digital Marketplace Activities

Investigations also found communities with up to 9,000 participants selling the experimental drug using Telegram's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up channels with thousands of users, filled with photos of slimming results, glowing testimonials and step-by-step guides for preparing or injecting at home.

Within moments of joining one community, a seller posted contact information, where the majority of transactions occur. The seller provided an instruction manual and promised shipping within two days. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about weight, medical conditions or previous experience.

Product Details and Pricing

Inside these groups, posts display black plastic parcels with postal service labels, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at residence with purified liquid, or pre-filled pens usually priced at £160 for 20mg. When asked how long a injector should be used, vendors give contradictory answers varying between a several days to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for Telegram stated it actively monitored dangerous material on its service including material that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are injecting materials they cannot confirm. Even if the science behind retatrutide is valid, these digital versions may not contain what they advertise,” stated Jason Murphy, the head of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor linked the increase in demand to current cost increases for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to social media. But fake treatments are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she explained.

Her team has already seen patients harmed by self-injection from unverified suppliers. “We recognize the disappointment, but buying from messaging apps or communication platforms is taking chances with your health,” stated the doctor. “These materials could be impure or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company said retatrutide was in third stage research studies and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this time no one can market [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a company experimental product not yet approved … may subject patients to potentially serious medical dangers”.